Ultragenyx Pharmaceutical Inc Sustainability Reports
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases. The company's diverse portfolio includes approved products and clinical-stage candidates spanning biologics, small molecules, and gene therapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900EV44GVDN1DCX77
FIGI: BBG001V2MJJ2
2 reports from 2024 to 2025